Profile photo Harry Heijerman

Harry Heijerman

Full Professor

Strategic program(s):

Biography

Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center  Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology. 

Recent publications

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population Julie Semenchuk, Yumi Naito, Susan C Charman, Siobhán B Carr, Jamie Duckers, Stephanie Y Cheng, Bruce C Marshall, Albert Faro, Alexander Elbert, Christopher H Goss, Pierre-Régis Burgel, Carla Colombo, Marco Salvatore, Nataliya Kashirskaya, Laura Kirwan, Peter G Middleton, Lutz Naehrlich, Maria Dolores Pastor-Vivero, Andreas Jung, Egil Bakkeheim, Anna Zolin, Annalisa Orenti, Domenique D Zomer-van Ommen, Marco Zampoli, Anne L Stephenson, , Harry Heijerman, Karin de Winter-de Groot
Journal of Cystic Fibrosis, 2026, vol. 25, p.670-677
Side versus adverse effects of elexacaftor/tezacaftor/ivacaftor therapy in people with CF J B A Gorgels, J Koopman, E C van der Hout, R W Hofland, H G M Heijerman, I Bronsveld
Respiratory Medicine, 2026, vol. 253
Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis Bente L. Aalbers, Gimano D. Amatngalim, Ellen M. Aarts, Lisa W. Rodenburg, Loes A. den Hertog-Oosterhoff, Harry G.M. Heijerman, Jeffrey M. Beekman
Journal of Personalized Medicine, 2026, vol. 16
Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor P. van Mourik, E. C. van der Hout, H. D. Luijk, R. W. Hofland, A. H.W. Bruns, H. G.M. Heijerman, I. Bronsveld
Respiratory Medicine Case Reports, 2025, vol. 57
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis Johanna P van Gemert, Bart Luijk, Merel E Hellemons, Klara A Visser, Carina M E Hansen, Renske van der Meer, C Tji Gan, Hester van der Vaart, Onno W Akkerman, Willie N Steenhuis, Marieke Verkleij, Harry G M Heijerman, Erik A M Verschuuren,
JHLT Open, 2025, vol. 7
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis Julie Semenchuk, Yumi Naito, Susan C. Charman, Siobhán B. Carr, Stephanie Y. Cheng, Bruce C. Marshall, Albert Faro, Alexander Elbert, Hector H. Gutierrez, Christopher H. Goss, Bulent Karadag, Pierre Régis Burgel, Carla Colombo, Marco Salvatore, Rita Padoan, Géraldine Daneau, Satenik Harutyunyan, Nataliya Kashirskaya, Laura Kirwan, Peter G. Middleton, Rasa Ruseckaite, Isabelle de Monestrol, Lutz Naehrlich, Pedro Mondejar-Lopez, Andreas Jung, Jacqui van Rens, Egil Bakkeheim, Annalisa Orenti, Domenique Zomer-van Ommen, Luiz Vicente RF da Silva-Filho, Flavia Fonseca Fernandes, Marco Zampoli, Anne L. Stephenson, Irena Kasmi, Ouardia Drali, Sabine Burghart, Andrea Lakatos-Krepcik, Johannes Eder, Peter Jaksch, Katharina Kainz, Margit Kallinger, Alexander Leitner, Marta Mozdzen, Andreas Pfleger, Sabine Renner, Martin Stadlinger, Christina Thir, Emil Nuriyev, Harry Heijerman, Renske van der Meer, Karin de Winter-de Groot,
Journal of Cystic Fibrosis, 2024, vol. 23, p.815-822

External positions

Voorzitter adviesraad zorg - Expertise op het gebied van Cystic Fibrosis in mijn functie van longarts - Nederlandse Cystic Fibrosis stichting